UNSPSC 51433939: Teludipine hydrochloride

This classification denotes a calcium channel blocker with the molecular formula C28H38N2O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7P6B96QLKN, chemically known as 3,5-pyridinedicarboxylic acid, 2-((dimethylamino)methyl)-4-(2-(3-(1,1-dimethylethoxy)-3-oxo-1-propenyl)phenyl)-1,4-dihydro-6-methyl-, diethyl ester, (e)- but more generally known as teludipine hydrochloride, which bears US NIH Compound Identifier 6436165.

Most nations, for tariff and trade purposes, schedule teludipine hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, TELUDIPINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Teludipine hydrochloride bears US NLM identifiers UMLS ID C0292595 and NCI Concept Code C66585. SMILES: CCOC(=O)C1=C(NC(=C(C1C2CCCCC2/C=C/C(=O)OC(C)(C)C)C(=O)OCC)CN(C)C)C.CL.

UNSPSC 51433939 Teludipine hydrochloride is a Commodity code that captures prescription medications and active pharmaceutical ingredients procured by state and local health agencies, emergency services, and pharmacy benefit programs. Recent state and local solicitations under this code reflect demand for advanced life support medications, generic multi-source pharmaceuticals, and direct-to-manufacturer prescription fulfillment capabilities. The work encompasses supply of finished pharmaceutical products—vials, injections, tablets—meeting FDA compliance, cGMP certification, Drug Supply Chain Security Act requirements, and OSHA Safety Data Sheet documentation, with typical contract terms ranging from one to two years and renewal or extension options.

Activity under the code involves state health and human services commissions, cooperative purchasing alliances, and municipal fire-rescue departments. The City of Tampa's Purchasing Department solicited sealed bids for Advanced Life Support Medications (IFB 26P00188) due April 8, 2026, seeking 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and SLBE sheltered-market participation. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP (S1070000015802) with response deadline March 26, 2026, for generic multi-source pharmaceuticals and OTC products to be distributed across state and local government facilities in Minnesota and Oregon, requiring manufacturer compliance with cGMP, DSCSA, and wholesaler relationships with AmerisourceBergen, Cardinal Health, and Morris & Dickson. Texas Health and Human Services Commission posted an RFI (HHS0017013) in early April 2026 to assess vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. Recent activity spans Florida, Minnesota, Oregon, and Texas.